Nootropics Market size is expected to reach $5.31 billion by 2026, rising at a market growth of 13.2%. CAGR during the forecast period 2026

Nootropics Market size is expected to reach $5.31 billion by 2026, rising at a market growth of 13.2%. CAGR during the forecast period 2026

Nootropics Market To Reach USD 5.32 Billion By 2026 The Global Nootropics Market was valued at USD 1.96 billion in 2018 and is expected to reach USD 5.32 billion by the year 2026, at a CAGR of 13.2%. Nootropics are compounds that enhance the cognitive performance of an individual. These substance, also known as smart drugs, are a class of ingredients which can boost the memory, enhance creativity levels, decision making capabilities and improve brain performance.

Nootropics medication are of two types, prescription and nonprescription. Prescription medication gives stimulant effects, counteracting the symptoms of medical conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease, or narcolepsy while nonprescription medications are used to boost mental performance due to their cholinergic mechanisms.

Request for FREE sample report @https://www.reportsanddata.com/sample-enquiry-form/2509

The market for these substances is anticipated to get augmented by factors such as the increasing demand for brain boosters owing to the competitive work environment across various domains, rising demand from the sports industry for brain and improved decision making, and the growing awareness regarding mental illnesses. However, the side effects associated with regular consumption of these pills, lack of awareness among consumers regarding these products, addiction to the drug and hesitation among people to visit psychiatrists or neurologists in emerging countries would impede the growth of this market.

In market segmentation by manufacturers, the report covers the following companies:-Accelerated Intelligence Inc., AlternaScript; HVMN, Onnit Labs, Inc., Peak Nootropics, Teva Pharmaceutical Industries, Purelife bioscience Co., Ltd., United Pharmacies, SupNootropic bio co., Ltd., and Powder City

With the increasing number of nootropic consumers, more recently, the drug modafinil (brand name: Provigil) has become the brain-booster of choice. Modafinil is intended to improve wakefulness in people with narcolepsy, obstructive sleep apnea, or work condition change according to the FDA. But when people take it without these factors, it has been related to changes in alertness, strength, decision-making and concentration. Other leading pharmaceutical companies in this domain are focused on bringing new products in the market with multiple functions. For instance, Neurohacker Collective, the human optimization company, launched the first liquid nootropic, Qualia Nootropic Energy Shot, claimed to improve brain energy levels.

North America holds the highest market share in this industry with the highest number of nootropics consumers in the region. A large percentage of adult population in this region consumes multi-vitamin tablets for improving functional abilities. Moreover, the U.S. Food and Drug Administration has classified the nonprescription product as Generally Regarded as Safe (GRAS).

For the purpose of this report, Reports and Data has segmented the Nootropics market on the basis of drugs type, application, distribution channel and region:

Drug Type Outlook (Revenue in Million USD; 2019-2026)
Prescription Nootropics
OTC Nootropics

Application Outlook (Revenue in Million USD; 2019-2026)
Memory Enhancement
Mood & Depression
Attention & Focus
Longevity & Anti-aging
Sleep & Recovery
Anxiety

Distribution Channel Outlook (Revenue in Million USD; 2019-2026)
Offline
Online

Get Your Copy at Discounted Price @ https://www.reportsanddata.com/discount-enquiry-form/2509

Regional Outlook (Revenue in Million USD; 2019-2026)
North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Further key findings from the report suggest:

The application type segment is dominated by the memory enhancement type nootropics owing to the challenging work environment demanding potential employees. It is anticipated to grow at a CAGR of 13.7 % during the forecast period.

HVMN, a U.S. based manufacturer and seller of ketone associated products launched HVMN Ketone at the beginning of 2018, which is claimed to enhance both physical and cognitive performance.

In recent years, consumer have shifted to organic nootropics as well such as coffee, matcha tea, green tea, kucha tea, spinach, beets, peanuts, eggs, liver, brahmi, arctic root, turmeric, ginseng, pine bark, and fish oil.

According to the American Exercise Council (ACE), around 50% of the consumers in the U.S. prefer to buy natural ingredient products. The growth in vegan population is expected to drive demand for natural products in developed regions such as Europe and North America.
Manufacturers for Nootropics are focused on natural ingredients to satisfy the growing demand. For instance, Gaia Herbs launched a new product in April 2019 called Bacopa a vegan supplement made using natural ingredient. It contains lemon balm, saffron and spearmint.North America remains the key revenue generating geographical segment in this market. The geographical segment accounted for USD 740.1 million in 2018. Availability presence of key market players in the region, rising focus on precision medicine, and rising awareness about nootropics applications, are among the key factors driving the market growth for Nootropics in this regionAccess Full Report Description, TOC, Figure, Chart, etc. @https://www.reportsanddata.com/report-detail/nootropics-marketThere are 10 Chapters that describe the development of the global Nootropics MarketThe report is spread across 10 Chapters that encompass the analysis of the global Nootropics Market Chapter 1 covers the introduction of the Wearable Materials Market, product scope, market overview, market opportunities, market challenges, and market drivers;Chapter 2 talks about the top vendors, with an in-depth analysis of their sales, revenue and pricing strategies for the duration 2016 and 2017;Chapter 3 displays the competitive nature of the market by discussing the competition among top vendors in the sector. It dissects the market using sales, revenue and market share data for 2016 and 2017;Chapter 4, shows the global market by regions and the proportionate size of each market region based on sales, revenue, and market share of Nootropics Market, for the period 2012-2017;Continue…Contact Us:John Watson Head of Business Development Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Reports and Data | Web: www.reportsanddata.com News: www.reportsanddata.com/market-news Connect with us: Facebook | LinkedIn | Twitter 40 Wall St. 28th floor New York City, NY 10005 United StatesAbout Us:Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends […]

Read more at www.openpr.com

Sharing is caring!

Leave a Reply